Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
2.395
-0.005 (-0.21%)
Oct 16, 2026, 10:04 AM EDT - Market open
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $141.53 million as of October 16, 2026. It is the 22,960th most valuable company in the world and the 3,852nd biggest in the United States. Its market cap has decreased by 35.87% in one year.
Market Cap
141.53M
Enterprise Value
-17.57M
1-Year Change
-35.87%
Global Rank
Country Rank
#3,852 United States
Category
ChartMarket Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has decreased from $173.16M to $141.53M, a decrease of -18.26%. That is a compound annual growth rate of -2.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 141.53M | -50.45% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veraxa Biotech AG | 156.96M |
| Compass Therapeutics | 155.42M |
| Adagene | 155.10M |
| MediWound | 154.67M |
| Canton Strategic Holdings | 147.41M |
| NovaBridge Biosciences | 146.74M |
| Jyong Biotech | 146.24M |
| Nkarta | 146.11M |